A multicenter survey of asymptomatic cryptococcal antigenemia among patients with advanced HIV disease in Nigeria

A multicenter survey of asymptomatic cryptococcal antigenemia among patients with advanced HIV disease in Nigeria

Show other versions (1)

As of 2018, cryptococcal antigen (CrAg) screening in patients with advanced human immunodeficiency virus (HIV) disease (AHD) was not routinely implemented in Nigeria despite being recommended in the national HIV treatment guidelines. Our aim was to determine the prevalence and risk factors for asymp...

Full description

Bibliographic Details
Main Authors:	Rita O. Oladele, Alexander M. Jordan, Joy U. Okaa, Iriagbonse I. Osaigbovo, Shuwaram A. Shettima, Nathan Y. Shehu, Adeyinka A. Davies, Yahaya Mohammed, Mary A. Alex-Wele, Garba Iliyasu, Jude C. Nwaokenye, Samuel A. Fayemiwo, Ubong A. Udoh, Titilola Gbajabiamila, David W. Denning, Tom M. Chiller
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLOS Global Public Health
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021610/?tool=EBI

Similar Items

A multicenter survey of asymptomatic cryptococcal antigenemia among patients with advanced HIV disease in Nigeria.
by: Rita O Oladele, et al.
Published: (2023-01-01)

Epidemiology of Cryptococcal antigenemia among HIV infected patients in southwestern Nigeria
by: Odekunle Bola Odegbemi, et al.
Published: (2019-10-01)

Prior subclinical histoplasmosis revealed in Nigeria using histoplasmin skin testing.
by: Rita O Oladele, et al.
Published: (2018-01-01)

Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program--Vietnam.
by: Rachel M Smith, et al.
Published: (2013-01-01)

Current epidemiology of histoplasmosis in Nigeria: A systematic review and meta-analysis
by: Bassey Ewa Ekeng, et al.
Published: (2023-01-01)

Standardization of IgG diagnostic cutoff in Nigerians
by: Rita O. Oladele, et al.
Published: (2021-10-01)

Underlying Cryptococcal Diseases and the Correlation With Serum Cryptococcal Antigen Titers in Hospitalized HIV-Infected Patients Screened Positive for Cryptococcal Antigenemia
by: Miaomiao Xu, et al.
Published: (2020-04-01)

Six months survival and risk factors for attrition for patients detected with cryptococcal antigenemia through screening in Malawi.
by: Master R O Chisale, et al.
Published: (2023-01-01)

Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.
by: Micol, R, et al.
Published: (2007)

Asymptomatic cryptococcal antigenemia in HIV-infected patients: a review of recent studies
by: Xiao-Lei Xu, et al.
Published: (2020-12-01)

Pulmonary and Extrapulmonary Manifestations of Fungal Infections Misdiagnosed as Tuberculosis: The Need for Prompt Diagnosis and Management
by: Bassey E. Ekeng, et al.
Published: (2022-04-01)

Utility of Cryptococcal Antigen Screening and Evolution of Asymptomatic Cryptococcal Antigenemia among HIV-Infected Women Starting Antiretroviral Therapy in Thailand
by: Candice K. Kwan MD, et al.
Published: (2014-09-01)

Screening for Cryptococcal Antigenemia in Anti-Retroviral Naïve AIDS Patients in Benin City, Nigeria
by: Favour Osazuwa, et al.
Published: (2012-05-01)

Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts
by: Martha P. Montgomery, et al.
Published: (2017-06-01)

High prevalence of Cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia.
by: Abere Shiferaw Alemu, et al.
Published: (2013-01-01)

Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda.
by: Elissa K Butler, et al.
Published: (2012-01-01)

Tackling cryptococcal meningitis in Nigeria, one-step at a time; the impact of training.
by: Rita O Oladele, et al.
Published: (2020-01-01)

Correction: High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique
Published: (2024-01-01)

Correction: High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique.
by: Robert Deiss, et al.
Published: (2024-01-01)

Cryptococcal antigenemia screening among human immunodeficiency virus-infected cases with tuberculosis: Chance and cost effectiveness
by: Sora Yasri, et al.
Published: (2018-01-01)

Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa.
by: Bruce A Larson, et al.
Published: (2016-01-01)

Cryptococcal Antigenemia in Anti-Retroviral Naïve AIDS Patients: Prevalence and Its Association with CD4 Cell Count
by: Oghomwen Favour Osazuwa, et al.
Published: (2012-05-01)

Cryptococcal antigenemia and its predictors among HIV infected patients in resource limited settings: a systematic review
by: Awoke Derbie, et al.
Published: (2020-06-01)

Cryptococcal Antigenemia in Anti-Retroviral Naïve AIDS Patients: Prevalence and Its Association with CD4 Cell Count
by: Evbaguehita Okuonghae, et al.
Published: (2012-05-01)

Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100–200 cells/mm3
by: James Wykowski, et al.
Published: (2020-01-01)

CRYPTOCOCCAL ANTIGENEMIA IN HIV/AIDS PATIENTS USING LATERAL FLOW IMMUNOASSAY DETECTION AT Dr. SOETOMO GENERAL HOSPITAL SURABAYA
by: Sajuni Widjaja, et al.
Published: (2018-03-01)

Fluconazole Resistance among Oral Candida Isolates from People Living with HIV/AIDS in a Nigerian Tertiary Hospital
by: Iriagbonse I. Osaigbovo, et al.
Published: (2017-12-01)

Triazole susceptibility of species: environmental survey in Lagos, Nigeria and review of the rest of Africa
by: Cynthia Abosede Campbell, et al.
Published: (2021-09-01)

Cryptococcal meningitis: a neglected NTD?
by: Molloy, S, et al.
Published: (2017)

{'en_US': 'Sero-prevalance of Cryptococcal Antigenemia in HIV Positive Individual having CD4 Counts <100 Cells/mm3'}
by: Sundar Khadka, et al.
Published: (2021-12-01)

Rotavirus antigenemia in children is associated with viremia.
by: Sarah E Blutt, et al.
Published: (2007-04-01)

HIV-Associated Cryptococcal Disease in Resource-Limited Settings: A Case for “Prevention Is Better Than Cure”?
by: Rita O. Oladele, et al.
Published: (2017-12-01)

Point of care tests for invasive fungal infections: a blueprint for increasing availability in Africa
by: Iriagbonse Iyabo Osaigbovo, et al.
Published: (2021-08-01)

Cryptococcal antigenemia and associated risk factors among ART‐naïve and ART‐experienced HIV‐infected peoples at selected health institutions of Mekelle, Northern Ethiopia
by: Kibra Hailu, et al.
Published: (2019-06-01)

Prevalence of Histoplasmosis among Persons with Advanced HIV Disease, Nigeria
by: Rita O. Oladele, et al.
Published: (2022-11-01)

Prevalence and Associated Factors of Cryptococcal Antigenemia in HIV-Infected Patients with CD4 < 200 Cells/µL in São Paulo, Brazil: A Bayesian Analysis
by: Evanthia Vetos Mimicos, et al.
Published: (2022-12-01)

Gastrointestinal Histoplasmosis: A Descriptive Review, 2001–2021
by: Bassey E. Ekeng, et al.
Published: (2023-03-01)

PP65 antigenemia in the diagnosis of cytomegalovirus infection in AIDS patients
by: RC Capela, et al.
Published: (2012-01-01)

Cryptococcal meningitis: A neglected NTD?
by: Síle F Molloy, et al.
Published: (2017-06-01)

Cost-effectiveness of reflex laboratory-based cryptococcal antigen screening for the prevention and treatment of cryptococcal meningitis in Botswana [version 1; peer review: 2 approved]
by: Mark W. Tenforde, et al.
Published: (2019-09-01)